Overview

Ursodeoxycholic Acid in C. Difficile Infection

Status:
Recruiting
Trial end date:
2024-06-30
Target enrollment:
Participant gender:
Summary
The primary objective of the study is to assess tolerability and adherence to treatment with ursodeoxycholic acid
Phase:
N/A
Details
Lead Sponsor:
Nottingham University Hospitals NHS Trust
Treatments:
Ursodeoxycholic Acid